financetom
Business
financetom
/
Business
/
Bristol-Myers Squibb Swings to Q1 Non-GAAP Loss, Revenue Rises; Provides 2024 Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bristol-Myers Squibb Swings to Q1 Non-GAAP Loss, Revenue Rises; Provides 2024 Guidance
Apr 25, 2024 5:00 AM

07:40 AM EDT, 04/25/2024 (MT Newswires) -- Bristol-Myers Squibb ( BMY ) reported a Q1 non-GAAP loss Thursday of $4.40 per diluted share, compared with non-GAAP earnings of $2.05 a year earlier.

Analysts surveyed by Capital IQ expected a normalized loss of $4.42.

Revenue for the quarter ended March 31 was $11.87 billion, compared with $11.34 billion a year earlier.

Analysts surveyed by Capital IQ expected $11.45 billion.

The company said it expects 2024 non-GAAP EPS of $0.40 to $0.70. Analysts polled by Capital IQ expect $0.66.

Shares of Bristol-Myers Squibb ( BMY ) were down more than 1% in recent premarket activity on Thursday.

Price: 48.03, Change: -0.83, Percent Change: -1.70

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Air India in talks for major new narrow-body jet order, sources say
Air India in talks for major new narrow-body jet order, sources say
Jun 1, 2025
NEW DELHI, June 1 (Reuters) - Tata Group's Air India is in talks with Airbus and Boeing ( BA ) for a major new order potentially including some 200 extra single-aisle planes, topping up a mammoth 2023 deal as the flag carrier seeks to pre-empt a growing jet shortage, industry sources said. The order discussions, which one of the sources...
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Jun 1, 2025
* Therapy shrank tumors in 62% of patients in small trial * Result was not lasting beyond a few months for most patients * We're on the right track, scientist says By Julie Steenhuysen CHICAGO, June 1 (Reuters) - A Gilead Sciences ( GILD )-backed therapy made with a patient's own white blood cells shrank tumors in 62% of patients...
Air India in talks for major new narrow-body jet order, sources say
Air India in talks for major new narrow-body jet order, sources say
Jun 1, 2025
NEW DELHI (Reuters) -Tata Group's Air India is in talks with Airbus and Boeing ( BA ) for a major new order potentially including some 200 extra single-aisle planes, topping up a mammoth 2023 deal as the flag carrier seeks to pre-empt a growing jet shortage, industry sources said. The order discussions, which one of the sources said could involve...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved